CAR-T Manufacturing: Guidance Anticipates Platform Challenges And Opportunities
Executive Summary
Draft from US FDA advises sponsors on how to draw from platform knowledge, while anticipating issues associated with emerging centralized and distributed manufacturing approaches for autologous and allogeneic products and their viral vectors.